Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer.
Saved in:
| Title: | Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer. |
|---|---|
| Authors: | Crossman BE; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Harmon RL; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Iida M; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Adams JM; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Lin CY; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Glitchev CE; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Juang TD; Department of Biomedical Engineering, University of Wisconsin, Madison, WI, United States., Kerr SC; School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, United States., Alexandridis RA; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, United States., Hyun M; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, United States., Yang DT; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States., Kang I; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Salgia R; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Wheeler DL; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.; School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 May 05; Vol. 15, pp. 1579214. Date of Electronic Publication: 2025 May 05 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1579214 |
